The patient completed the protocol. They restricted sleep when asked, left the bed when wakefulness persisted, protected the stimulus conditions and brought the diary back with the discipline the clinician requested. Improvement appeared, then failed to consolidate.
That clinical scene is delicate because it can easily be misread as nonadherence, resistance or insufficient motivation. The clinician who has watched the process closely knows that explanation is too crude. The intervention reached its layer. The patient’s system did not remit.
The distinction protects both the patient and the protocol. CBT-I remains correct for behavioral insomnia and conditioned wakefulness. It structures the conditions under which sleep can be relearned. But when the organism remains in persistent activation, the behavioral learning may occur inside a system that is not available to retain it.
Vgontzas and colleagues describe chronic insomnia with objective short sleep duration as a biologically severe phenotype associated with activation of the HPA axis and sympathetic nervous system. Riemann and colleagues place persistent hyperarousal across neuroendocrine, autonomic and cortical systems at the center of the insomnia model. These sources do not prove that every patient has the same biology. They allow the clinician to name a possibility: the nonremission may belong to activation that the behavioral protocol was not designed to settle directly.
Ayurveda offers a second layer of reading. A Vata pattern may fail to consolidate because irregularity and nervous dispersion keep the system unstable. A Pitta pattern may keep intensity active long after the instruction has been understood. A Kapha pattern may show inertia and slow response even when the intervention is correctly performed. These are not substitute diagnoses. They make the receiving terrain visible.
Transcendental Meditation (TM) is relevant only as regulation of activation. Walton and colleagues associate regular TM practice with lower neuroendocrine activation related to stress, including cortisol. That is not a sleep-treatment claim. It is a way of locating a layer that may need to become quieter before behavioral learning can hold.
The clinician who sees the nonremitting patient this way does not ask for more effort in the same language. They ask what pattern is shaping the response.
The clinician who recognizes one of their own patients in this article already has the right clinical question.
The next step is learning to distinguish treatment failure from regulatory persistence without weakening the place of standard sleep care.
It is not what the patient failed to do. It is what formation makes it possible to read the layer that remained active after the protocol did its work.